Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Apply
HLX-1502
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step